ACP5 and pulmonary fibrosis: Collectively, our data support the notion that ACP5 is involved in the progression of pulmonary fibrosis; therefore, strategies aimed at silencing or suppressing Acp5 could be viable therapies against pulmonary fibrosis in clinical settings.